These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8750720)

  • 1. Prevention of cyclosporine A-induced renal vasoconstriction by the endothelin receptor antagonist SB 209670.
    Brooks DP; Contino LC
    Eur J Pharmacol; 1995 Dec; 294(2-3):571-6. PubMed ID: 8750720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.
    Brooks DP; dePalma PD; Gellai M; Nambi P; Ohlstein EH; Elliott JD; Gleason JG; Ruffolo RR
    J Pharmacol Exp Ther; 1994 Nov; 271(2):769-75. PubMed ID: 7965795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats.
    Cavarape A; Endlich K; Feletto F; Parekh N; Bartoli E; Steinhausen M
    Kidney Int; 1998 Apr; 53(4):963-9. PubMed ID: 9551405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
    Bunting MW; Widdop RE
    Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat.
    Gellai M; Fletcher T; Pullen M; Nambi P
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R254-61. PubMed ID: 8760228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1.
    Bloom IT; Bentley FR; Garrison RN
    Surgery; 1993 Aug; 114(2):480-7; discussion 487-8. PubMed ID: 8342150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
    Ohlstein EH; Nambi P; Lago A; Hay DW; Beck G; Fong KL; Eddy EP; Smith P; Ellens H; Elliott JD
    J Pharmacol Exp Ther; 1996 Feb; 276(2):609-15. PubMed ID: 8632328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of nitric oxide.
    Gellai M; De Wolf R; Fletcher T; Nambi P
    Pharmacology; 1997 Dec; 55(6):299-308. PubMed ID: 9413859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal endothelin in FK506-induced nephrotoxicity in spontaneously hypertensive rats.
    Uchida J; Miura K; Yamanaka S; Kim S; Iwao H; Nakatani T; Kishimoto T
    Jpn J Pharmacol; 1998 Jan; 76(1):39-49. PubMed ID: 9517403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
    Pollock DM; Opgenorth TJ
    Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation.
    Pollock DM; Opgenorth TJ
    Am J Physiol; 1993 Jan; 264(1 Pt 2):R222-6. PubMed ID: 8430883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for endothelin ETA receptors in regulation of renal function in spontaneously hypertensive rats.
    Bird JE; Webb ML; Giancarli MR; Chao C; Dorso CR; Asaad MM
    Eur J Pharmacol; 1995 Dec; 294(1):183-9. PubMed ID: 8788430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the endothelin receptor antagonist, SB 209670 on cyclosporine-induced nephrotoxicity.
    Ishikawa A; Suzuki K; Fujita K
    Transplant Proc; 1998 Feb; 30(1):40-2. PubMed ID: 9474951
    [No Abstract]   [Full Text] [Related]  

  • 14. SB 234551, a novel endothelin--A receptor antagonist, unmasks endothelin-induced renal vasodilatation in the dog.
    Brooks DP; DePalma PD; Pullen M; Elliott JD; Ohlstein EH; Nambi P
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S339-41. PubMed ID: 9595475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
    Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
    Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin receptor subtypes in the pathogenesis of angioplasty-induced neointima formation in the rat: a comparison of selective ETA receptor antagonism and dual ETA/ETB receptor antagonism using BQ-123 and SB 209670.
    Douglas SA; Vickery-Clark LM; Louden C; Elliott JD; Ohlstein EH
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S186-9. PubMed ID: 8587358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function.
    Forbes JM; Hewitson TD; Becker GJ; Jones CL
    Kidney Int; 2001 Apr; 59(4):1333-41. PubMed ID: 11260394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1.
    Pollock DM
    Physiol Genomics; 2001 Jun; 6(1):39-43. PubMed ID: 11395545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of radiocontrast-induced nephrotoxicity by the endothelin receptor antagonist, SB 209670.
    Brooks DP; DePalma PD
    Nephron; 1996; 72(4):629-36. PubMed ID: 8730433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.
    Ohlstein EH; Beck GR; Douglas SA; Nambi P; Lago MA; Gleason JG; Ruffolo RR; Feuerstein G; Elliott JD
    J Pharmacol Exp Ther; 1994 Nov; 271(2):762-8. PubMed ID: 7965794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.